Oxidative injury is a common consequence of BMPR2 mutations

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Research

Background:

• Hereditary pulmonary arterial hypertension (PAH) is primarily caused by mutations in the BMPR2 gene.
• Understanding the molecular consequences of diverse BMPR2 mutations is crucial for elucidating disease etiology.
• This study investigates common molecular outcomes across different classes of BMPR2 mutations.

Purpose of the Study:

• To identify shared molecular consequences resulting from various types of BMPR2 mutations.
• To gain insights into the molecular underpinnings of hereditary pulmonary arterial hypertension.

Main Methods:

• Stable transfection of vascular smooth muscle cells with distinct BMPR2 mutation classes (ligand binding, kinase, cytoplasmic tail domains).
• Measurement of oxidized lipids (isoprostanes, isofurans) in lung tissue of transgenic mice and urine of human patients.
• Immunohistochemistry and electron microscopy on mouse and human lung tissue to assess oxidative stress and mitochondrial morphology.

Main Results:

• Increased superoxide and peroxide production, and altered oxidative stress gene expression were observed across BMPR2 mutation classes in cell culture.
• Transgenic mice with BMPR2 mutations exhibited elevated oxidized lipids in lungs, indicating increased reactive oxygen species (ROS) of mitochondrial origin.
• Oxidative stress was confirmed to be vascular-specific in both BMPR2 mutant mice and HPAH patients, with observed mitochondrial abnormalities.

Conclusions:

• Increased oxidative stress, originating from mitochondria, represents a common molecular consequence of BMPR2 mutations.
• This finding holds true across different mutation types and is observed in cell culture, animal models, and human patients.
• Identifying oxidative stress as a common pathway provides a potential therapeutic target for hereditary pulmonary arterial hypertension.